95 related articles for article (PubMed ID: 21912116)
1. Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions.
Kielland LG; Vage RA; Eide GE; Sørnes S; Naess A
Chemotherapy; 2011; 57(4):339-44. PubMed ID: 21912116
[TBL] [Abstract][Full Text] [Related]
2. Effect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro.
Okuyan B; Izzettin FV; Sancar M; Ertaş O; Cevikbaş A; Gürer US
Int Immunopharmacol; 2005 Jul; 5(7-8):1337-42. PubMed ID: 15914338
[TBL] [Abstract][Full Text] [Related]
3. Effect of antituberculous drugs, isoniazid, pyrazinamide and rifampicin, on chemiluminescence of the human polymorphonuclear leukocytes.
Demkow U; Małkowska-Zwierz W; Rogala E; Skopińska-Rózewska E; Lewandowski Z
Folia Biol (Praha); 1995; 41(5):257-62. PubMed ID: 8714775
[TBL] [Abstract][Full Text] [Related]
4. Linezolid and human polymorphonuclear leukocyte function.
Naess A; Stenhaug Kilhus K; Nystad TW; Sørnes S
Chemotherapy; 2006; 52(3):122-4. PubMed ID: 16612054
[TBL] [Abstract][Full Text] [Related]
5. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
Ahn HC; Lee YC
Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
[TBL] [Abstract][Full Text] [Related]
6. Tigecycline attenuates polymorphonuclear leukocyte (PMN) receptors but not functions.
Naess A; Andreeva H; Sørnes S
Acta Pharm; 2011 Sep; 61(3):297-302. PubMed ID: 21945908
[TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro.
Zeis BM
Chemotherapy; 1988; 34(1):56-60. PubMed ID: 2832129
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of the action of drugs in the short-course chemotherapy].
Mitchison DA
Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
[No Abstract] [Full Text] [Related]
9. Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
DeCoster DJ; Vena RM; Callister SM; Schell RF
Clin Microbiol Infect; 2005 May; 11(5):372-8. PubMed ID: 15819863
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
11. [Response to the short-course chemotherapy in patients presenting initial resistance].
Mitchison DA
Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
[No Abstract] [Full Text] [Related]
12. Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs.
Immanuel C; Gurumurthy P; Ramachandran G; Venkatesan P; Chandrasekaran V; Prabhakar R
Indian J Med Res; 2003 Sep; 118():109-14. PubMed ID: 14700343
[TBL] [Abstract][Full Text] [Related]
14. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Seung KJ; Gelmanova IE; Peremitin GG; Golubchikova VT; Pavlova VE; Sirotkina OB; Yanova GV; Strelis AK
Clin Infect Dis; 2004 Nov; 39(9):1321-8. PubMed ID: 15494909
[TBL] [Abstract][Full Text] [Related]
15. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
16. Protein Binding of First-Line Antituberculosis Drugs.
Alghamdi WA; Al-Shaer MH; Peloquin CA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735566
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2.
Bredius RG; de Vries CE; Troelstra A; van Alphen L; Weening RS; van de Winkel JG; Out TA
J Immunol; 1993 Aug; 151(3):1463-72. PubMed ID: 8335940
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
Danckwerts MP; Ebrahim S; Pillay V
Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of the reproductive hormones on the oxidative burst activity of polymorphonuclear leucocytes from cows: a flow cytometric study.
Chaveiro A; Moreira da Silva F
Reprod Domest Anim; 2010 Oct; 45(5):e40-5. PubMed ID: 19788527
[TBL] [Abstract][Full Text] [Related]
20. A whole blood bactericidal assay for tuberculosis.
Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
